These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 9678512)

  • 1. Pleomorphic mitochondrial and different filamentous inclusions in inflammatory myopathies associated with mtDNA deletions.
    Molnar M; Schröder JM
    Acta Neuropathol; 1998 Jul; 96(1):41-51. PubMed ID: 9678512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymyositis with mitochondrial pathology or atypical form of sporadic inclusion body myositis: case series and review of the literature.
    Papadimas GK; Kokkinis C; Xirou S; Chrysanthou M; Kararizou E; Papadopoulos C
    Rheumatol Int; 2019 Aug; 39(8):1459-1466. PubMed ID: 31055642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple mitochondrial DNA deletions in hereditary inclusion body myopathy.
    Jansson M; Darin N; Kyllerman M; Martinsson T; Wahlström J; Oldfors A
    Acta Neuropathol; 2000 Jul; 100(1):23-8. PubMed ID: 10912916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial abnormalities in inclusion-body myositis.
    Oldfors A; Moslemi AR; Jonasson L; Ohlsson M; Kollberg G; Lindberg C
    Neurology; 2006 Jan; 66(2 Suppl 1):S49-55. PubMed ID: 16432145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial DNA deletions in muscle fibers in inclusion body myositis.
    Oldfors A; Moslemi AR; Fyhr IM; Holme E; Larsson NG; Lindberg C
    J Neuropathol Exp Neurol; 1995 Jul; 54(4):581-7. PubMed ID: 7602331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin immunostaining and inclusion body myositis: study of 30 patients with inclusion body myositis.
    Prayson RA; Cohen ML
    Hum Pathol; 1997 Aug; 28(8):887-92. PubMed ID: 9269823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the mitochondrial DNA abnormalities in the skeletal muscle of patients with inclusion body myositis.
    Horvath R; Fu K; Johns T; Genge A; Karpati G; Shoubridge EA
    J Neuropathol Exp Neurol; 1998 May; 57(5):396-403. PubMed ID: 9596410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial DNA variants in inclusion body myositis characterized by deep sequencing.
    Hedberg-Oldfors C; Lindgren U; Basu S; Visuttijai K; Lindberg C; Falkenberg M; Larsson Lekholm E; Oldfors A
    Brain Pathol; 2021 May; 31(3):e12931. PubMed ID: 33354847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital myopathy with tubular aggregates and tubulofilamentous IBM-type inclusions.
    Fidziańska A; Kamińska A; Ryniewicz B
    Neuropediatrics; 2005 Feb; 36(1):35-9. PubMed ID: 15776320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory myopathies with mitochondrial pathology and protein aggregates.
    Temiz P; Weihl CC; Pestronk A
    J Neurol Sci; 2009 Mar; 278(1-2):25-9. PubMed ID: 19101700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial abnormalities and peripheral neuropathy in inflammatory myopathy, especially inclusion body myositis.
    Schröder JM; Molnar M
    Mol Cell Biochem; 1997 Sep; 174(1-2):277-81. PubMed ID: 9309700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-2, Bcl-x, and Bax expression by immunohistochemistry in inclusion body myositis: a study of 27 cases.
    Prayson RA; Yu AC
    Arch Pathol Lab Med; 2001 Oct; 125(10):1326-30. PubMed ID: 11570908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative morphometric study of muscle in inclusion body myositis.
    Verma A; Bradley WG; Soule NW; Pendlebury WW; Kelly J; Adelman LS; Chou SM; Karpati G; Brenner JF
    J Neurol Sci; 1992 Oct; 112(1-2):192-8. PubMed ID: 1335036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional relevance of mitochondrial abnormalities in sporadic inclusion body myositis.
    Joshi PR; Vetterke M; Hauburger A; Tacik P; Stoltenburg G; Hanisch F
    J Clin Neurosci; 2014 Nov; 21(11):1959-63. PubMed ID: 25311418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial pathology in inclusion body myositis.
    Lindgren U; Roos S; Hedberg Oldfors C; Moslemi AR; Lindberg C; Oldfors A
    Neuromuscul Disord; 2015 Apr; 25(4):281-8. PubMed ID: 25638290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-Cell-Mediated Inflammatory Myopathies in HIV-Positive Individuals: A Histologic Study of 19 Cases.
    Hiniker A; Daniels BH; Margeta M
    J Neuropathol Exp Neurol; 2016 Mar; 75(3):239-45. PubMed ID: 26843609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inclusion body myositis and neuromuscular diseases with rimmed vacuoles].
    Figarella-Branger D; Pellissier JF; Pouget J; Calore EE; Azulay JP; Desnuelle C; Serratrice G
    Rev Neurol (Paris); 1992; 148(4):281-90. PubMed ID: 1332175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid filaments in inclusion body myositis. Novel findings provide insight into nature of filaments.
    Mendell JR; Sahenk Z; Gales T; Paul L
    Arch Neurol; 1991 Dec; 48(12):1229-34. PubMed ID: 1668977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis.
    Nogalska A; Terracciano C; D'Agostino C; King Engel W; Askanas V
    Acta Neuropathol; 2009 Sep; 118(3):407-13. PubMed ID: 19557423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of clusterin and the aggresome in abnormal protein deposits in myofibrillar myopathies and inclusion body myositis.
    Ferrer I; Carmona M; Blanco R; Moreno D; Torrejón-Escribano B; Olivé M
    Brain Pathol; 2005 Apr; 15(2):101-8. PubMed ID: 15912881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.